Tamoxifen perturbs lipid bilayer order and permeability: Comparison of DSC, fluorescence anisotropy, Laurdan generalized polarization and carboxyfluorescein leakage studies

Biophysical Chemistry

Volumn 90, Issue 2, 2001, Pages 157-173

  Engelke, Maria ^a   Bojarski, Piotr ^b   Bloß, Ralf ^a   Diehl, Horst ^a  

^a UNIVERSITY OF BREMEN   (Germany)

^b UNIVERSITY OF GDA SK   (Poland)

Author keywords

1,6 Diphenyl 1,3,5 hexatriene (DPH); 1 4 (Trimethylammonium)phenyl 6 phenylhexa 1,3,5 triene (TMA DPH); Carboxyfluorescein leakage; Differential scanning calorimetry (DSC); Laurdan; Tamoxifen

Indexed keywords

1 [4 (TRIMETHYLAMMONIUM)PHENYL] 6 PHENYL HEXA 1,3,5 TRIENE; 1,6 DIPHENYL 1,3,5 HEXATRIENE; CARBOXYFLUORESCEIN; DIPALMITOYLPHOSPHATIDYLCHOLINE; ESTROGEN RECEPTOR; FLUORESCENT DYE; LAURDAN; PHOSPHATIDYLCHOLINE; TAMOXIFEN; UNCLASSIFIED DRUG;

ANISOTROPY; ANTINEOPLASTIC ACTIVITY; ARTICLE; ARTIFICIAL MEMBRANE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG MECHANISM; EGG YOLK; FLUORESCENCE; INTERMETHOD COMPARISON; LIPID BILAYER; MEMBRANE PERMEABILITY; MEMBRANE STRUCTURE; POLARIZATION; PRIORITY JOURNAL; TEMPERATURE;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; 2-NAPHTHYLAMINE; CALORIMETRY, DIFFERENTIAL SCANNING; CELL MEMBRANE PERMEABILITY; DIPHENYLHEXATRIENE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCEINS; FLUORESCENCE POLARIZATION; LAURATES; LIPID BILAYERS; TAMOXIFEN; TEMPERATURE;

EID: 0035836585     PISSN: 03014622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-4622(01)00139-9     Document Type: Article

References (24)

1. Tamoxifen: new membrane mediated mechanisms of action and therapeutic advances
2. Use of tamoxifen for breast cancer: twenty-eight years later
3. Non-estroidal antiestrogen inhibition of protein kinase C in human corpus luteum and placenta
4. Non-steroidal antiestrogens induce apoptosis in HL60 and MOLT3 leucemic cells; involvement of reactive oxygen radicals and protein kinase C
5. A reliable procedure to estimate drug partitioning in biomembranes
6. The anticancer drug tamoxifen induces changes in the physical properties of model and native membranes
7. Tamoxifen and related compounds decrease membrane fluidity in liposomes. Mechanism for the antioxidant action of tamoxifen and relevance to its anticancer and cardioprotective actions?
8. The antioxidant action of synthetic estrogens involves decreased membrane fluidity: relevance to their potential use as anticancer and cardioprotective agents compared to tamoxifen?
9. Interaction of the anticancer drug tamoxifen with human erythrocyte membrane and molecular models
10. Effect of estradiol and tamoxifen on brain membranes: investigation by infrared and fluorescence spectroscopy
11. Tamoxifen-model membrane interactions: an FT-IR study
12. Use of Bacillus stearothermophilus as a model to study tamoxifen-membrane interactions
13. Fluorescence spectroscopy in the study of membrane fluidity: model membrane systems
14. Quantification of lipid phases in phospholipid vesicles by the generalized polarization of Laurdan fluorescence
15. Interactions of Laurdan with phosphatidylcholine liposomes: a high-pressure FTIR study
16. Effect of inhalation anaesthetics on the phase behavior, permeability and order of phosphatidylcholine bilayers
17. Perturbation of artificial and biological membranes by organic compounds of aliphatic, alicyclic and aromatic structure
18. Calorimetric determination of phospholipids with ammonium ferrothiocyanate
19. Stability of liposomes on long-term storage
20. Fluidity parameters of lipid regions determined by fluorescence polarization
21. Microviscosity and order in the hydrocarbon region of micelles and membranes determined with fluorescent probes. I. Synthetic micelles
22. Theory of the main lipid bilayer phase transition
23. Interaction of detergents with lipid vesicles
24. Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure